Api Acquisition Sub Inc (AVRX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart
Ticker: AVRX


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
164 +0.7%
2.60
USD 427 		164 +0.7% 2.60 USD 427
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
1,036 +4.6%
2.61
USD 2,708 		1,036 +4.6% 2.61 USD 2,708
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
800 +3.7%
2.60
USD 2,077 		800 +3.7% 2.60 USD 2,077
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.54
USD 254 		100 +0.5% 2.54 USD 254
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.49
USD 249 		100 +0.5% 2.49 USD 249
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
500 +2.4%
2.49
USD 1,244 		500 +2.4% 2.49 USD 1,244
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
632 +3.1%
2.48
USD 1,570 		632 +3.1% 2.48 USD 1,570
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.46
USD 246 		100 +0.5% 2.46 USD 246
2008-01-23 2008-01-23 B Purchase

Carter Kenneth C

President and CEO

Executive Director
1,400 +7.4%
2.65
USD 3,710 		1,400 +7.4% 2.65 USD 3,710
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.64
USD 528 		200 -0.9% 2.64 USD 528
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
400 -1.8%
2.63
USD 1,052 		400 -1.8% 2.63 USD 1,052
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.58
USD 516 		200 -0.9% 2.58 USD 516
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.53
USD 506 		200 -0.9% 2.53 USD 506
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
300 -1.3%
2.50
USD 750 		300 -1.3% 2.50 USD 750
2008-01-23 2008-01-17 S Sale

Carter Kenneth C

President and CEO

Executive Director
732 -3.1%
2.45
USD 1,793 		732 -3.1% 2.45 USD 1,793
2006-08-31 2006-08-30 B Purchase

Carter Kenneth C

President and CEO

Executive Director
3,000 +14.4%
2.99
USD 8,970 		3,000 +14.4% 2.99 USD 8,970
2006-08-30 2006-08-28 B Purchase

Hamilton J Michael

Chief Medical Officer

Officer
2,500 +1250.0%
3.09
USD 7,725 		2,500 +1250.0% 3.09 USD 7,725
2006-08-24 2006-08-22 B Purchase

Carter Kenneth C

President and CEO

Executive Director
900 +3.8%
3.26
USD 2,934 		900 +3.8% 3.26 USD 2,934
2006-08-24 2006-08-22 B Purchase

Carter Kenneth C

President and CEO

Executive Director
100 +0.4%
3.27
USD 327 		100 +0.4% 3.27 USD 327
2006-08-24 2006-08-22 B Purchase

Carter Kenneth C

President and CEO

Executive Director
1,000 +4.4%
3.28
USD 3,280 		1,000 +4.4% 3.28 USD 3,280
2005-10-18 2005-10-04 B Purchase

EuclidSR Biotechnology Partners, L.P.

Non-Executive Director
203,900 +inf%
10.50
USD 2,140,950 		203,900 +inf% 10.50 USD 2,140,950
2005-10-06 2005-10-04 B Purchase

Beneden Patrick Van

Non-Executive Director Large shareholder
27,210 +17.6%
10.50
USD 285,705 		27,210 +17.6% 10.50 USD 285,705
2005-10-06 2005-10-04 B Purchase

Beneden Patrick Van

Non-Executive Director Large shareholder
154,190 +inf%
10.50
USD 1,618,995 		154,190 +inf% 10.50 USD 1,618,995
2005-10-06 2005-10-04 B Purchase

ROYSTON IVOR

Non-Executive Director
10,628 +8.5%
10.50
USD 111,594 		10,628 +8.5% 10.50 USD 111,594
2005-10-06 2005-10-04 B Purchase

ROYSTON IVOR

Non-Executive Director
125,372 +inf%
10.50
USD 1,316,406 		125,372 +inf% 10.50 USD 1,316,406
2005-10-06 2005-10-04 B Purchase

OXFORD BIOSCIENCE PARTNERS III LP

Large shareholder
1,717 +27.5%
10.50
USD 18,029 		1,717 +27.5% 10.50 USD 18,029
2005-10-06 2005-10-04 B Purchase

OXFORD BIOSCIENCE PARTNERS III LP

Large shareholder
13,795 +27.5%
10.50
USD 144,848 		13,795 +27.5% 10.50 USD 144,848
2005-10-06 2005-10-04 B Purchase

OXFORD BIOSCIENCE PARTNERS III LP

Large shareholder
20,693 +27.5%
10.50
USD 217,277 		20,693 +27.5% 10.50 USD 217,277
2005-10-06 2005-10-04 B Purchase

OXFORD BIOSCIENCE PARTNERS III LP

Large shareholder
145,195 +27.5%
10.50
USD 1,524,548 		145,195 +27.5% 10.50 USD 1,524,548
2005-10-06 2005-10-04 B Purchase

GIMV NV

Large shareholder
27,210 +17.6%
10.50
USD 285,705 		27,210 +17.6% 10.50 USD 285,705
2005-10-06 2005-10-04 B Purchase

GIMV NV

Large shareholder
154,190 +inf%
10.50
USD 1,618,995 		154,190 +inf% 10.50 USD 1,618,995
2005-10-06 2005-10-04 B Purchase

Whitaker Raymond J

Non-Executive Director
101,950 +100.0%
10.50
USD 1,070,475 		101,950 +100.0% 10.50 USD 1,070,475
2005-10-06 2005-10-04 B Purchase

Whitaker Raymond J

Non-Executive Director
101,950 +inf%
10.50
USD 1,070,475 		101,950 +inf% 10.50 USD 1,070,475
// ... existing code ... // ... rest of the file ...